So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it.
Justin Wrote an Additional Post after our Discussion
On to the Wee…
Latest posts by Scott Weingart (see all)
- EMCrit Podcast 242 – ED Nephrology with Joel Topf aka KidneyBoy - March 9, 2019
- EMCrit Podcast 241 – Sepsis Update 2019 - February 21, 2019
- EMCrit Podcast 240 – Renal Compartment Syndrome & It's all about the Venous Side and We've Been Fracking it up for Years - February 10, 2019